Header Logo

Connection

Paul Carvey to Animals

This is a "connection" page, showing publications Paul Carvey has written about Animals.
Connection Strength

1.366
  1. Dopamine receptors and the persistent neurovascular dysregulation induced by methamphetamine self-administration in rats. J Pharmacol Exp Ther. 2014 Nov; 351(2):432-9.
    View in: PubMed
    Score: 0.063
  2. Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction. Neuroreport. 2011 Dec 07; 22(17):923-8.
    View in: PubMed
    Score: 0.052
  3. The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. J Neurochem. 2009 Oct; 111(2):291-314.
    View in: PubMed
    Score: 0.044
  4. Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging. Exp Neurol. 2009 Apr; 216(2):312-20.
    View in: PubMed
    Score: 0.043
  5. Neuroinflammation and peripheral immune infiltration in Parkinson's disease: an autoimmune hypothesis. Cell Transplant. 2008; 17(4):363-72.
    View in: PubMed
    Score: 0.040
  6. TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol Dis. 2007 Apr; 26(1):36-46.
    View in: PubMed
    Score: 0.037
  7. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp Neurol. 2006 Jun; 199(2):499-512.
    View in: PubMed
    Score: 0.035
  8. Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis. Cell Transplant. 2006; 15(3):239-50.
    View in: PubMed
    Score: 0.035
  9. 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability. Eur J Neurosci. 2005 Sep; 22(5):1158-68.
    View in: PubMed
    Score: 0.034
  10. Intra-parenchymal injection of tumor necrosis factor-alpha and interleukin 1-beta produces dopamine neuron loss in the rat. J Neural Transm (Vienna). 2005 May; 112(5):601-12.
    View in: PubMed
    Score: 0.032
  11. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Exp Neurol. 2004 Dec; 190(2):373-83.
    View in: PubMed
    Score: 0.032
  12. Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience. 2004; 124(3):619-28.
    View in: PubMed
    Score: 0.030
  13. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front Biosci. 2003 Sep 01; 8:s826-37.
    View in: PubMed
    Score: 0.029
  14. Prenatal cocaine exposure induces an attenuation of uterine blood flow in the rat. Neurotoxicol Teratol. 2002 Mar-Apr; 24(2):143-8.
    View in: PubMed
    Score: 0.027
  15. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res. 2002 Jan 31; 133(1):27-35.
    View in: PubMed
    Score: 0.026
  16. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord. 2002 Jan; 17(1):116-24.
    View in: PubMed
    Score: 0.026
  17. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp Neurol. 2001 Sep; 171(1):98-108.
    View in: PubMed
    Score: 0.026
  18. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp Neurol. 2001 Jun; 169(2):219-30.
    View in: PubMed
    Score: 0.025
  19. Striatal trophic activity is reduced in the aged rat brain. Brain Res. 2000 Feb 21; 856(1-2):301-9.
    View in: PubMed
    Score: 0.023
  20. Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine. J Neural Transm (Vienna). 2000; 107(2):159-76.
    View in: PubMed
    Score: 0.023
  21. Prenatal cocaine exposure reduces glial cell line-derived neurotrophic factor (GDNF) in the striatum and the carotid body of the rat: implications for DA neurodevelopment. Brain Res Dev Brain Res. 1999 Dec 10; 118(1-2):231-5.
    View in: PubMed
    Score: 0.023
  22. Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res. 1999 May; 296(2):235-46.
    View in: PubMed
    Score: 0.022
  23. Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures. J Pharmacol Exp Ther. 1999 Apr; 289(1):202-10.
    View in: PubMed
    Score: 0.022
  24. Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Neurology. 1999 Jan 01; 52(1):16-21.
    View in: PubMed
    Score: 0.021
  25. The magnitude of brain dopamine depletion from prenatal cocaine exposure is a function of uterine position. Neurotoxicol Teratol. 1998 Jul-Aug; 20(4):373-82.
    View in: PubMed
    Score: 0.021
  26. Uterine position determines the extent of dopamine reduction after chronic prenatal cocaine exposure. Ann N Y Acad Sci. 1998 May 30; 844:314-23.
    View in: PubMed
    Score: 0.020
  27. Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures. Brain Res. 1998 Apr 27; 791(1-2):137-45.
    View in: PubMed
    Score: 0.020
  28. 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes. Eur J Pharmacol. 1998 Apr 17; 347(1):51-6.
    View in: PubMed
    Score: 0.020
  29. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp Neurol. 1998 Feb; 149(2):411-23.
    View in: PubMed
    Score: 0.020
  30. The effects of storage conditions and trophic supplementation on the survival of fetal mesencephalic cells. Cell Transplant. 1997 May-Jun; 6(3):297-307.
    View in: PubMed
    Score: 0.019
  31. Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole. J Neural Transm (Vienna). 1997; 104(2-3):209-28.
    View in: PubMed
    Score: 0.019
  32. Loss of striatal DA innervation increases striatal trophic activity directed at DA neurons in culture. Exp Neurol. 1996 Aug; 140(2):184-97.
    View in: PubMed
    Score: 0.018
  33. Comparison of the neurotoxicity of dihydroxyphenylalanine stereoisomers in cultured dopamine neurons. Clin Neuropharmacol. 1996 Aug; 19(4):360-5.
    View in: PubMed
    Score: 0.018
  34. Prenatal cocaine exposure and postnatal hypoxia independently decrease carotid body dopamine in neonatal rats. Neurotoxicol Teratol. 1996 May-Jun; 18(3):283-7.
    View in: PubMed
    Score: 0.018
  35. Isolation and manipulation of rostral mesencephalic tegmental progenitor cells from rat. Cell Transplant. 1995 May-Jun; 4(3):335-42.
    View in: PubMed
    Score: 0.017
  36. Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking. Eur J Neurosci. 2014 Aug; 40(4):2707-14.
    View in: PubMed
    Score: 0.016
  37. Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture. Exp Neurol. 1994 Mar; 126(1):15-24.
    View in: PubMed
    Score: 0.015
  38. Hypoxia after prenatal cocaine attenuates striatal dopamine and neurotrophic activity. Neurotoxicol Teratol. 1994 Mar-Apr; 16(2):177-81.
    View in: PubMed
    Score: 0.015
  39. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov Disord. 2014 Jul; 29(8):999-1009.
    View in: PubMed
    Score: 0.015
  40. Alterations in striatal neurotrophic activity induced by dopaminergic drugs. Pharmacol Biochem Behav. 1993 Sep; 46(1):195-204.
    View in: PubMed
    Score: 0.015
  41. Effect of cocaine in early gestation on striatal dopamine and neurotrophic activity. Pediatr Res. 1993 Sep; 34(3):389-92.
    View in: PubMed
    Score: 0.015
  42. Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol. 1992 Dec; 15(6):488-500.
    View in: PubMed
    Score: 0.014
  43. Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures. Exp Neurol. 1991 Oct; 114(1):28-34.
    View in: PubMed
    Score: 0.013
  44. An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity. Exp Neurol. 2011 Sep; 231(1):160-70.
    View in: PubMed
    Score: 0.013
  45. Dopamine distribution and behavioral alterations resulting from dopamine infusion into the brain of the lesioned rat. J Neurosurg. 1991 Jan; 74(1):105-11.
    View in: PubMed
    Score: 0.012
  46. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm. Eur J Pharmacol. 1990 Aug 02; 184(1):43-53.
    View in: PubMed
    Score: 0.012
  47. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacol Biochem Behav. 1990 Feb; 35(2):291-300.
    View in: PubMed
    Score: 0.011
  48. Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor. Prog Brain Res. 1990; 82:693-7.
    View in: PubMed
    Score: 0.011
  49. Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum. Clin Neuropharmacol. 1989 Oct; 12(5):425-34.
    View in: PubMed
    Score: 0.011
  50. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide. Brain Res. 2009 Apr 10; 1265:196-204.
    View in: PubMed
    Score: 0.011
  51. LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig. Prog Neuropsychopharmacol Biol Psychiatry. 1989; 13(1-2):199-210.
    View in: PubMed
    Score: 0.011
  52. An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation. Neurosci Lett. 1988 Nov 22; 94(1-2):192-7.
    View in: PubMed
    Score: 0.011
  53. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Life Sci. 1988; 42(22):2207-15.
    View in: PubMed
    Score: 0.010
  54. Effects of dopamine antagonists and apomorphine on regional energy metabolism in rat CNS. Clin Neuropharmacol. 1987 Jun; 10(3):247-60.
    View in: PubMed
    Score: 0.010
  55. The effect of bilateral kainic acid-induced lateral habenula lesions on dopamine-mediated behaviors. Brain Res. 1987 Apr 14; 409(1):193-6.
    View in: PubMed
    Score: 0.009
  56. Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide. Neurochem Int. 2007 Mar; 50(4):671-80.
    View in: PubMed
    Score: 0.009
  57. Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res. 2006 May 23; 1090(1):35-44.
    View in: PubMed
    Score: 0.009
  58. The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity. Eur J Pharmacol. 1986 Jan 21; 120(2):193-9.
    View in: PubMed
    Score: 0.009
  59. L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update. Adv Neurol. 1986; 43:509-17.
    View in: PubMed
    Score: 0.009
  60. Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J Biol Chem. 2005 Jun 03; 280(22):21418-26.
    View in: PubMed
    Score: 0.008
  61. Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism. Exp Neurol. 2005 Feb; 191 Suppl 1:S60-7.
    View in: PubMed
    Score: 0.008
  62. Animal models of tardive dyskinesias. Clin Neuropharmacol. 1983 Jun; 6(2):129-35.
    View in: PubMed
    Score: 0.007
  63. Animal models of tardive dyskinesia: their use in the search for new treatment methods. Mod Probl Pharmacopsychiatry. 1983; 21:5-20.
    View in: PubMed
    Score: 0.007
  64. The role of the serotonin system in animal models of myoclonus. Adv Neurol. 2002; 89:244-8.
    View in: PubMed
    Score: 0.007
  65. Estrogen supplementation in the posthypoxic myoclonus rat model. Clin Neuropharmacol. 2001 Jan-Feb; 24(1):58-61.
    View in: PubMed
    Score: 0.006
  66. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science. 2000 Oct 27; 290(5492):767-73.
    View in: PubMed
    Score: 0.006
  67. Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons. Mol Pharmacol. 2000 Mar; 57(3):589-94.
    View in: PubMed
    Score: 0.006
  68. Posthypoxic myoclonus in the rat: natural history, stability, and serotonergic influences. Mov Disord. 2000; 15 Suppl 1:39-46.
    View in: PubMed
    Score: 0.006
  69. Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Brain Res Mol Brain Res. 1999 Jan 22; 64(1):141-8.
    View in: PubMed
    Score: 0.005
  70. Analysis of 9-fluorenylmethyloxycarbonyl derivatives of catecholamines by high performance liquid chromatography, liquid chromatography/mass spectrometry and tandem mass spectrometry. Rapid Commun Mass Spectrom. 1999; 13(18):1869-77.
    View in: PubMed
    Score: 0.005
  71. Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons. Neuroscience. 1998 Oct; 86(3):701-7.
    View in: PubMed
    Score: 0.005
  72. Prenatal cocaine: effect on hypoxic ventilatory responsiveness in neonatal rats. Respir Physiol. 1996 Nov; 106(2):161-9.
    View in: PubMed
    Score: 0.005
  73. Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures. J Neural Transm Suppl. 1990; 29:195-206.
    View in: PubMed
    Score: 0.003
  74. The effect of thioridazine on haloperidol induced behavioral hypersensitivity. Life Sci. 1986 May 12; 38(19):1707-14.
    View in: PubMed
    Score: 0.002
  75. Drug-induced myoclonus. Adv Neurol. 1986; 43:251-64.
    View in: PubMed
    Score: 0.002
  76. The pathophysiology of tardive dyskinesia. J Clin Psychiatry. 1985 Apr; 46(4 Pt 2):38-41.
    View in: PubMed
    Score: 0.002
  77. Neuroleptic-induced dopamine hyposensitivity. Life Sci. 1984 Apr 09; 34(15):1475-9.
    View in: PubMed
    Score: 0.002
  78. Long-term suppression of central serotonergic activity by corticosteroids: a possible model of steroid-responsive myoclonic disorders. Neurology. 1982 Jul; 32(7):772-5.
    View in: PubMed
    Score: 0.002
  79. Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration. Eur J Pharmacol. 1982 Mar 12; 78(3):335-43.
    View in: PubMed
    Score: 0.002
  80. Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig. Adv Neurol. 1982; 35:213-9.
    View in: PubMed
    Score: 0.002
  81. The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig. Life Sci. 1981 May 11; 28(19):2173-8.
    View in: PubMed
    Score: 0.002
  82. Correlation between daily dosage of chlorpromazine and subsequent supersensitivity. Adv Biochem Psychopharmacol. 1980; 24:569-72.
    View in: PubMed
    Score: 0.001
  83. Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior. Neurology. 1979 Dec; 29(12):1622-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.